Home / Ceftriaxone / Belgium
BE ATC J01DD04 · updated 2 Nov 2026
Ceftriaxone shortage in Belgium
Is there a Ceftriaxone shortage in Belgium?
Yes. As of 2 Nov 2026, 1 Ceftriaxone product is reported short in Belgium, the first since 27 Oct 2026. The company estimate for the return is 29 Nov 2026. Main reason: manufacturing problem.
Also short in Italy, Spain, Czechia, Japan. All countries.
Affected products in Belgium
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| BE | Ceftriaxone Fresenius Kabi 1 g inj./inf. sol. (pwdr.) i.m./i.v. vial 10 x 1 g | Fresenius Kabi | 27 Oct 2026 | 29 Nov 2026 | Manufacturing problem Delay in production |
Source
FAMHP (Federal Agency for Medicines and Health Products), PharmaStatus / SAMv2. Official list. All authorised packs with a declared temporary unavailability.